Y-Intercept (HK)’s Gossamer Bio GOSS Stock Holding History

Y-Intercept (HK)’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-540	Closed	-$7.11K	–	1769
2026 Q2	$7.11K	Buy	+540	New	+$12.1K	﹤0.01%	1650
2024 Q2	–	Sell	-1,135	Closed	-$107K	–	1577
2024 Q1	$107K	Buy	+1,135	New	+$100K	0.01%	1273
2023 Q3	–	Sell	-826	Closed	-$79.3K	–	1244
2023 Q2	$79.3K	Sell	826 -1,421	-63%	-$142K	0.01%	1139
2023 Q1	$226K	Buy	+2,247	New	+$344K	0.03%	902

Other funds holding GOSS

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Y-Intercept (HK)'s GOSS Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 540 shares — an estimated $7.11K sold.

Y-Intercept (HK) first reported a position in GOSS in Q1 2023 and held it in 4 quarters. The position peaked at $226K in Q1 2023. 10 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

Y-Intercept (HK) reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 540 Gossamer Bio shares in Q3 2026, an estimated $7.11K.
Y-Intercept (HK) first reported a position in Gossamer Bio in Q1 2023 and held it in 4 quarters.
Y-Intercept (HK)'s Gossamer Bio position peaked at $226K in Q1 2023.
10 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.